Filing Details
- Accession Number:
- 0001181431-10-030382
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-01 13:00:00
- Reporting Period:
- 2010-05-27
- Filing Date:
- 2010-06-01
- Accepted Time:
- 2010-06-01 14:57:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1355818 | L Judy Brown | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-27 | 6,062 | $35.85 | 19,206 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-05-27 | 5,358 | $20.50 | 24,564 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-05-27 | 11,420 | $60.14 | 13,144 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2010-05-27 | 6,062 | $0.00 | 6,062 | $35.85 |
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2010-05-27 | 5,358 | $0.00 | 5,358 | $20.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-08-25 | 2018-08-25 | No | 4 | M | Direct |
| 0 | 2009-08-30 | 2017-08-30 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $60.127 to $60.162. For all transactions reported in this Form 4 utilizing a weighted avaerage price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each seperate price within the range.
Billionaire Hedge Funds
